1. [BP.02.06] MATRIX METALLOPROTEINASE 2 AND 9 POLYMORPHISMS ARE ASSOCIATED WITH TARGET ORGAN DAMAGE IN OBESE RESISTANT HYPERTENSIVE SUBJECTS. (September 2017) Authors: Ritter, A.; De Faria, A.; Sabbatini, A.; Barbaro, N.; Correa, N.; Brunelli, V.; Almeida, A.; Pires, N.; Modolo, R.; Moreno, H. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [PP.10.05] ALTERATIONS IN METALLOPROTEINASE 9 AND TISSUE INHIBITOR 1 LEVELS IN RESISTANT HYPERTENSION AND THEIR RELATIONSHIP TO LEFT VENTRICULAR HYPERTROPHY. (September 2016) Authors: Barbaro, N.; Sabbatini, A.; Ritter, A.; Almeida, A.; Faria, A.; Brunelli, V.; Correa, N.; Modolo, R.; Pinho, C.; Fontana, V.; Moreno, H. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. [PP.10.06] OBESITY-DEPENDENT EFFECTS ON MMP-9 LEVELS IN RESISTANT HYPERTENSION. (September 2016) Authors: Ritter, A.; Faria, A.; Modolo, R.; Barbaro, N.; Sabbatini, A.; Corrêa, N.; Brunelli, V.; Pires, N.; Almeida, A.; Moreno, H. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. [PP.10.07] DEREGULATION OF SOLUBLE ADHESION MOLECULES IN RESISTANCE TO ANTIHYPERTENSIVE TREATMENT AND ITS ROLE IN CARDIOVASCULAR REMODELING. (September 2016) Authors: De Faria, A.; Ritter, A.; Sabbatini, A.; Corrêa, N.; Brunelli, V.; Catharina, A.; Barbaro, N.; Almeida, A.; Modolo, R.; Moreno, H. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. [PP.10.24] EFFECTS OF TNF-ALPHA INHIBITON ON HEMODYNAMIC PARAMETERS AND BIOMARKERS IN RESISTANT HYPERTENSION: BACKGROUND, RATIONALE, AND DESIGN. (September 2016) Authors: De Faria, A.; Ritter, A.; Catharina, A. Santa; Brunelli, V.; Correa, N.; Sabbatini, A.; Almeida, A.; Barbaro, N.; Moreno, H.; Modolo, R. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PP.40.14: LEPTIN AND LEPTIN RECEPTOR GENE POLYMORPHISMS ARE ASSOCIATED WITH CLINICAL AND METABOLIC PARAMETERS IN RESISTANT HYPERTENSION. (June 2015) Authors: De Faria, A.; Modolo, R.; Ritter, A.; Sabbatini, A.; Barbaro, N.; Corrêa, N.; Brunelli, V.; Moreno, H. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PP.40.20: NEW EVALUATION APPROACH OF PHARMACOLOGICAL ADHERENCE OF RESISTANCE HYPERTENSION PATIENTS. (June 2015) Authors: Corrêa, N.; Ritter, A.M.; Faria, A.P.; Fontana, V.; Barbaro, N.; Sabbatini, A.; Brunelli, V.; Modolo, R.; Moreno, H. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗